CGB8 | Chorionic gonadotropin, beta polypeptide 8 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CGB5 | Chorionic gonadotropin, beta polypeptide 5 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
ISM2 | Isthmin 2 | Predicted secreted proteins
| | | | | Tissue enriched |
ADAM12 | ADAM metallopeptidase domain 12 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
MAGEA11 | Melanoma antigen family A, 11 | | | | | | Group enriched |
HSD17B1 | Hydroxysteroid (17-beta) dehydrogenase 1 | Enzymes
| | | | | Tissue enriched |
CGB2 | Chorionic gonadotropin, beta polypeptide 2 | Predicted secreted proteins
| | | | | Tissue enriched |
CXorf67 | Chromosome X open reading frame 67 | | | | | | Group enriched |
LIN28B | Lin-28 homolog B (C. elegans) | | | | | | Tissue enriched |
NPFFR2 | Neuropeptide FF receptor 2 | G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
HOXA13 | Homeobox A13 | Cancer-related genes Disease related genes Transcription factors
| | | | | Group enriched |
CLIC3 | Chloride intracellular channel 3 | Plasma proteins Transporters
| | | | | Group enriched |
CORO6 | Coronin 6 | | | | | | Group enriched |
FOXO4 | Forkhead box O4 | Cancer-related genes Disease related genes RAS pathway related proteins Transcription factors
| | | | | Tissue enriched |
SH2D5 | SH2 domain containing 5 | | | | | | Group enriched |
ARID3A | AT rich interactive domain 3A (BRIGHT-like) | Transcription factors
| | | | | Tissue enhanced |
CCNE1 | Cyclin E1 | Cancer-related genes
| | | | | Tissue enhanced |
CGB7 | Chorionic gonadotropin, beta polypeptide 7 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
COL4A2 | Collagen, type IV, alpha 2 | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
EGFR | Epidermal growth factor receptor | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
HSPA6 | Heat shock 70kDa protein 6 (HSP70B') | Plasma proteins
| | | | | Tissue enhanced |
IGF2BP3 | Insulin-like growth factor 2 mRNA binding protein 3 | | | | | | Tissue enhanced |
MFSD2A | Major facilitator superfamily domain containing 2A | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
MORC4 | MORC family CW-type zinc finger 4 | Cancer-related genes
| | | | | Tissue enhanced |
OLR1 | Oxidized low density lipoprotein (lectin-like) receptor 1 | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
PEG10 | Paternally expressed 10 | | | | | | Tissue enhanced |
PEG3 | Paternally expressed 3 | Transcription factors
| | | | | Tissue enhanced |
PITX2 | Paired-like homeodomain 2 | Disease related genes Transcription factors
| | | | | Tissue enhanced |
SLC2A1 | Solute carrier family 2 (facilitated glucose transporter), member 1 | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
TFAP2A | Transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) | Disease related genes Transcription factors
| | | | | Tissue enhanced |
TFAP2C | Transcription factor AP-2 gamma (activating enhancer binding protein 2 gamma) | Transcription factors
| | | | | Tissue enhanced |
WNT7A | Wingless-type MMTV integration site family, member 7A | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |